CJ CheilJedang Corp.
Nucleotide
[Nucleotide]
Nucleotide is the collective term for IMP and GMP, and it is a higher value added business. Currently, the size of the global market for the Nucleotide amounts to $500 million and has been rapidly growing largely due to the processed food market expansion.So far, there are only six companies in the world producing Nucleotide and competition to dominate this market with a significant growth potential has been getting fierce.
CJ CheilJedang, which is Korea¡¯s biggest processed food maker and the world¡¯s No.1 Nucleotide producer has recently announced plans to expand its global production capacity further, as a part of its strategy to solidify its leadership in the global market for nucleotides.
According to the plan the Korean food maker will expand its annual Nucleotide production capacities by more than double in their Chinese plant and Indonesian plant, respectively in order to ultimately expand its global market share to be half of global
demand by the end of 2013. This plan reflects the Korean Nucleotide producer¡¯s determination to strengthen its top position in the Nucleotide global market.
In the meanwhile, CJ CheilJedang is geared to increase its exporting presence and explore new overseas markets. The bioscience business of CJ CheilJedang that has emerged as a new cash cow began with the establishment of the Gimpo Plant in 1964, which possessed advanced fermentation and purification technology.
Currently, CJ CheilJedang is manufacturing a variety of bioscience products, such as MSG, Nucleotide, Lysine, Threonine and Tryptophane, and supplying them to Korea and international markets. In 1988, CJ CheilJedang started to use Lysine in animal feeds as a growth stimulant.
The foundation for growth was secured with the establishment of a plant in Indonesia. In 1997, CJ CheilJedang built a Nucleotide plant in Jombang, Indonesia. In 2005 and 2007, a Lysine plant and a Nucleotide plant were established in Liaocheng, China. In 2007, CJ CheilJedang also completed construction of a lysine plantin Piracicaba, Brazil. In addition, the Nucleotide plant in Liaocheng expanded and the extension of Tryptophane plant facilities was promoted in Pasuruan, Indonesia in 2009. As such, CJ Bio is leading the globalization of the CJ Group.
The bioscience researchers of CJ CheilJedang make up the core technological research staff and are performing a pivotal role in promoting CJ as a global enterprise. In addition, these researchers are significantly contributing to Korea¡¯s bio-industry
achieving the highest standard in the world.
By continuously expanding global production bases, improving R&D and production competency to increase cost competitiveness, and strengthening business and technological marketing activities targeting global customers all over the world, CJ CheilJedang has become a global bioscience company.
According to the recent bioscience business expansion strategy of the CJ Group, CJ Bio is striving to achieve its vision of becoming the global leader in the world in the microbial fermentation industry by accumulating outstanding technological prowess and customer value after obtaining permits to invest in large-scale global projects.